This is always the dream with any buyout as this way we don't need to worry about the current SP, just the true value of CU6. The sky is the limit in these cases.
Looking at the preclinical data and the limited clinical data we have seen to date on bisPSMA it looks to be significantly superior over the approved PSMA theranostics. Combined with the ability to scale production (not yet proven, but credible) what CU6 has could be the sort of asset that triggers a bidding war.
The next 6 months is really critical - by then we should have a good idea how bisPSMA really performs in the clinic. 2024 is going to be an exciting year for all of us CU6 shareholders.
This is always the dream with any buyout as this way we don't...
- There are more pages in this discussion • 243 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.09 |
Change
-0.210(4.88%) |
Mkt cap ! $1.272B | |||
| Open | High | Low | Value | Volume |
| $4.30 | $4.30 | $4.08 | $3.493M | 835.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7459 | $4.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.12 | 9361 | 1 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.10 |
Change
-0.210 ( 4.15 %) |
||||
| Open | High | Low | Volume | ||
| $4.17 | $4.29 | $4.08 | 50363 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| CU6 (ASX) Chart |